share_log

Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Vander Hoek Michael

Dec 30, 2022 16:06
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more